The expression signature combining these 25 genes exhibited a strong correlation with the 3-gene ENTPD1/NT5E/ADORA3 signature in ER+ breast cancers in the TCGA BRCA cohort, and this relationship is also observed with each of the three genes individually (Figure 2A). This evidence concerns the gene ENTPD1 and breast cancer.